PH19663A - Active compound combination of kitasamycin and quinoxaline di-n-oxides - Google Patents

Active compound combination of kitasamycin and quinoxaline di-n-oxides

Info

Publication number
PH19663A
PH19663A PH27778A PH27778A PH19663A PH 19663 A PH19663 A PH 19663A PH 27778 A PH27778 A PH 27778A PH 27778 A PH27778 A PH 27778A PH 19663 A PH19663 A PH 19663A
Authority
PH
Philippines
Prior art keywords
kitasamycin
oxides
active compound
compound combination
hydrogen
Prior art date
Application number
PH27778A
Inventor
Peter Henry Selle
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6140231&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH19663(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PH19663A publication Critical patent/PH19663A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52Oxygen atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/137Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/195Antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Abstract

1. Active compound combination consisting of kitasamycin and 2-methyl-3-carboxamidoquinoxaline- -1,4-di-N-oxides of the general formula I see diagramm : EP0073390,P9,F2 wherein R**1 represents hydrogen, lower alkyl, lower alkoxy radicals and chlorine, R**2 represents hydrogen or a straight-chain or branched alkyl radical which is optionally substituted by a hydroxyl, lower alkoxy, carboalkoxy, mono- or dialkylamino radical, R**3 can represent hydrogen and wherein R**3 furthermore can be identical to or different from R**2 and in the case where R**2 is hydrogen R**3 can also represent the cyclohexyl radical and wherein in the case where R**2 and R**3 denote alkyl these radicals, together with the amide nitrogen atom, can be a constituent of a 5- or 6-membered heterocyclic ring system.
PH27778A 1981-08-27 1982-08-25 Active compound combination of kitasamycin and quinoxaline di-n-oxides PH19663A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813133888 DE3133888A1 (en) 1981-08-27 1981-08-27 ACTIVE COMBINATION OF KITASAMYCIN AND CHINOXALIN-DI-N-OXIDES

Publications (1)

Publication Number Publication Date
PH19663A true PH19663A (en) 1986-06-09

Family

ID=6140231

Family Applications (1)

Application Number Title Priority Date Filing Date
PH27778A PH19663A (en) 1981-08-27 1982-08-25 Active compound combination of kitasamycin and quinoxaline di-n-oxides

Country Status (12)

Country Link
EP (1) EP0073390B1 (en)
JP (1) JPS5852224A (en)
KR (1) KR860000275B1 (en)
AT (1) ATE20171T1 (en)
AU (1) AU552563B2 (en)
BR (1) BR8205020A (en)
DE (2) DE3133888A1 (en)
EG (1) EG15924A (en)
ES (1) ES515272A0 (en)
FI (1) FI70364C (en)
PH (1) PH19663A (en)
ZA (1) ZA826230B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3230273A1 (en) * 1982-08-14 1984-02-16 Bayer Ag, 5090 Leverkusen LIGHT-STABILIZED CHINOXALINE DI-N-OXIDES
DE3340931A1 (en) * 1983-11-11 1985-05-23 Bayer Ag, 5090 Leverkusen DUST-FREE CHINOXALIN-1,4-DI-N-OXIDE
JPH06701B2 (en) * 1983-12-01 1994-01-05 旭化成工業株式会社 Veterinary composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3535309A (en) * 1967-09-01 1970-10-20 Kitasato Inst Antibiotics and their production
DE1670935C3 (en) * 1967-10-04 1975-12-04 Bayer Ag, 5090 Leverkusen 2-Methyl-3-carboxamidoquinoxaline-1,4-dl-N-oxides, a process for their preparation and antibacterial agents containing these compounds
AT281841B (en) * 1968-10-03 1970-06-10 Bayer Ag PROCESS FOR THE PRODUCTION OF NEW 2-METHYL-3-CARBONIC ACIDAMIDO-QUINOXALINDI-N-OXIDEN- (1,4)
SU890961A3 (en) * 1976-01-20 1981-12-15 Циба-Гейги Аг (Фирма) Growth stimulating agent for animals
US4254120A (en) * 1978-12-19 1981-03-03 Ciba-Geigy Corporation Growth promoting quinoxaline-di-N-oxide carboxamides

Also Published As

Publication number Publication date
ES8400014A1 (en) 1983-10-16
DE3133888A1 (en) 1983-03-10
FI70364B (en) 1986-03-27
ATE20171T1 (en) 1986-06-15
FI822950A0 (en) 1982-08-25
KR860000275B1 (en) 1986-03-26
ES515272A0 (en) 1983-10-16
AU552563B2 (en) 1986-06-05
EG15924A (en) 1986-12-30
EP0073390A1 (en) 1983-03-09
KR840000903A (en) 1984-03-26
FI822950L (en) 1983-02-28
BR8205020A (en) 1983-06-07
ZA826230B (en) 1983-07-27
DE3271554D1 (en) 1986-07-10
EP0073390B1 (en) 1986-06-04
FI70364C (en) 1986-09-19
AU8774882A (en) 1983-03-03
JPS5852224A (en) 1983-03-28

Similar Documents

Publication Publication Date Title
NZ215008A (en) Heterocyclic compounds and herbicidal compositions
DE69919897D1 (en) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
PL216409A1 (en)
ES430709A1 (en) 1-(Imidazolyl-1)-2-aryloxy-3-hydroxy-alkanes
ES476343A1 (en) Cyclopentan-1-amines
MY102277A (en) Quinoline compounds
MY100115A (en) Nitrogen containing heterocyclic compounds, and their production and use.
GR3001356T3 (en) 3-vinyl and 3-ethinyl-beta-carboline derivatives, their preparation and their use as medicaments
MY102973A (en) Isoindolinyl alkyl piperazines
ZA832887B (en) 1-carboxyalkanoylindoline-2-carboxylic acid esters
AU552563B2 (en) Active compound of kitasamycin and quinoxaline di-n- oxides
MX9505054A (en) Bisphenol ester derivatives.
ES453881A1 (en) 1,3-dithiolo(4,5-b)pyrazin-2-ylidene-propanedinitrile 4-oxide
GR81580B (en)
NZ333854A (en) Intermediates for the preparation of 2-imidazoline-5-ones
ES8401066A1 (en) 1,5-substituted isoquinoline derivatives.
FR2501676B1 (en)
GR3020420T3 (en) Alkyl derivatives of trazodone with cns activity.
ES466682A1 (en) Organic compounds
ES469896A1 (en) Hydroxythiazolidine-2-thiones
ES456296A1 (en) 2-(Iminoethylidene)-pyrrolidines and tautomeric 2-(aminoethenyl)-1-pyrrolines
GR851530B (en)
ES433081A1 (en) 1{40 ,4{40 -Dihydro-1-methyl-spiro{8 piperidine and pyrolidine-2,3{40 (2{40 H)quinoline{9 {0 compounds
ES8300704A1 (en) Encainide N-oxide
DE3460030D1 (en) Alpha-alkoxylated n-(3,3,5- or 3,5,5-trimethylcyclohexen-1-yl)-n-alkyl or n-allyl-acetamides and their use in phytotoxic preparations